Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Centre Leon Berard · 2011
ClinicalTrials.gov · Datasets · License: Public Domain · 2011
Open Source ↗
overall-survivalprogression-free-survivalsafety
diffuse large b cell lymphoma, akt, mk 2206, objective response rate, progression free survival, overall survival, safety, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 978953
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.